This was the stock's second consecutive day of losses.

New US tariffs could disrupt the medtech industry, impacting major companies like Boston Scientific and Stryker. Read more ...

The stock's fall snapped a two-day winning streak.

Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.

Looking into the current session, Boston Scientific Inc. BSX shares are trading at $96.89, after a 3.16% drop. Over the past month, the stock fell by 1.95%, but over the past year ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

Boston Scientific plans to break ground soon on a major expansion in Maple Grove, a project that’s up for $1.66 million in ...

“Investors can gain exposure to the healthcare sector by owning the S&P 500 through a passively managed index fund or ETF.

Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...

Boston Scientific (BSX) closed the most recent trading day at $98.50, moving -1.55% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day. On ...

Boston Scientific Co. (NYSE:BSX – Get Free Report) has been assigned an average recommendation of “Buy” from the twenty-three research firms that are presently covering the stock, MarketBeat.com ...